Brimonidine tartrate ophthalmic solution 0.025%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Brimonidine tartrate ophthalmic solution 0.025%, covering 2017-04-28 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma [Phase 4]